Published in Eur Radiol on October 25, 2005
Cardiovascular magnetic resonance in the evaluation of heart failure. Heart (2007) 1.00
Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2013) 0.84
Focal macroscopic fat deposition within the right ventricular wall in asymptomatic patients undergoing screening EBCT coronary calcium scoring examinations. Int J Cardiovasc Imaging (2007) 0.82
Effect of the 2010 task force criteria on reclassification of cardiovascular magnetic resonance criteria for arrhythmogenic right ventricular cardiomyopathy. J Cardiovasc Magn Reson (2014) 0.81
Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med (1988) 5.22
Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol (2002) 2.22
Echocardiographic measurement of the normal adult right ventricle. Br Heart J (1986) 2.16
Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol (2003) 1.99
A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J (1987) 1.53
Arrhythmogenic right ventricular dysplasia. Annu Rev Med (1999) 1.52
Diagnosis of arrhythmogenic right ventricular dysplasia: a review. Radiographics (2002) 1.45
MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology (2003) 1.44
Usefulness of magnetic resonance imaging in diagnosis of arrhythmogenic right ventricular dysplasia and agreement with electrocardiographic criteria. Am J Cardiol (2003) 1.43
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol. Circulation (2003) 1.32
Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coll Cardiol (2001) 1.20
Assessment of right ventricular function by 16-detector-row CT: comparison with magnetic resonance imaging. Eur Radiol (2004) 1.17
Arrhythmogenic right ventricular dysplasia: MRI findings. Herz (2000) 1.17
Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging. J Am Coll Cardiol (1994) 1.05
Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia. Circulation (1997) 1.04
Arrhythmogenic right ventricular disease: MR imaging vs angiography. AJR Am J Roentgenol (1993) 0.98
Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol (2004) 0.91
Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking. Eur Heart J (2004) 0.89
Arrhythmia patterns in athletes with arrhythmogenic right ventricular dysplasia. Eur Heart J (1989) 0.86
MRI assessment of right ventricular dysplasia. Eur Radiol (2002) 0.84
Right ventricular dysplasia as a generalized cardiomyopathy? findings on magnetic resonance imaging. Eur Heart J (1995) 0.84
Is adipose tissue a normal component of the myocardium? Eur Heart J (1989) 0.83
Cardiac structure and function in the obese: a cardiovascular magnetic resonance imaging study. J Cardiovasc Magn Reson (2003) 0.82
Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies. Cardiol Rev (2001) 0.81
Arrhythmogenic right ventricular dysplasia: MR features. Eur Radiol (1997) 0.81
Exercise-induced ST elevation in patients with arrhythmogenic right ventricular dysplasia. J Electrocardiol (1999) 0.78
Ventricular tachycardias of right ventricular origin: markers of subclinical right ventricular disease. Am Heart J (1994) 0.78
Biventricular function in patients with nonischemic right ventricle tachyarrhythmias assessed with MR imaging. AJR Am J Roentgenol (1997) 0.75
MR demonstration of septal involvement in arrhythmogenic right ventricular dysplasia. Eur Radiol (2004) 0.75
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Universal definition of myocardial infarction. Circulation (2007) 11.69
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med (2006) 11.66
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J (2004) 7.84
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J (2007) 6.51
Circulating microRNAs in patients with coronary artery disease. Circ Res (2010) 6.28
Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med (2014) 5.25
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72
Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J (2006) 4.69
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J (2008) 4.42
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation (2003) 4.36
Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med (2013) 4.16
Soluble CD40 ligand in acute coronary syndromes. N Engl J Med (2003) 4.06
Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation (2002) 3.48
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J (2002) 3.36
Bivalirudin started during emergency transport for primary PCI. N Engl J Med (2013) 2.80
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation (2008) 2.62
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol (2008) 2.31
EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol (2009) 2.23
Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol (2010) 2.13
Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol (2005) 2.07
Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail (2009) 2.01
Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res (2006) 2.00
Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry. JACC Cardiovasc Imaging (2011) 1.93
Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. Eur Heart J (2009) 1.90
Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J Am Coll Cardiol (2003) 1.88
N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation (2005) 1.86
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol (2003) 1.85
Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J (2007) 1.81
Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy. Eur Heart J (2009) 1.78
Safety, efficacy, and indications of beta-adrenergic receptor blockade to reduce heart rate prior to coronary CT angiography. Radiology (2010) 1.73
Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation (2003) 1.67
European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson (2013) 1.60
Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace (2010) 1.59
Activated cell survival cascade protects cardiomyocytes from cell death in Tako-Tsubo cardiomyopathy. Eur J Heart Fail (2009) 1.57
N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J (2004) 1.57
Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J (2006) 1.55
Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry. Circulation (2009) 1.54
Cardiac troponin elevations in patients without acute coronary syndrome. Circulation (2002) 1.53
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. Eur Heart J (2009) 1.49
Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur Heart J (2012) 1.48
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. JACC Cardiovasc Imaging (2010) 1.47
The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials. J Am Coll Cardiol (2012) 1.46
Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Electrocardiol (2011) 1.45
Which standard biomarkers are useful for the evaluation of myocardial injury after pulmonary vein isolation with cryoballoon? Kardiol Pol (2011) 1.41
Elevated serum levels of neuropeptide Y in stress cardiomyopathy. Int J Cardiol (2010) 1.41
Prognostic value of placental growth factor in patients with acute chest pain. JAMA (2004) 1.40
Major determinants of myocardial injury after pulmonary vein isolation with radiofrequency ablation. Kardiol Pol (2012) 1.39
2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. Rev Esp Cardiol (Engl Ed) (2015) 1.39
Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J (2010) 1.36
N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation (2004) 1.27
Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol (2006) 1.15
Prospective randomized comparison of durability of bidirectional conduction block in the cavotricuspid isthmus in patients after ablation of common atrial flutter using cryothermy and radiofrequency energy: the CRYOTIP study. Heart Rhythm (2009) 1.14
Practical aspects of the management of pericardial disease. Heart (2003) 1.13
Decreased pulmonary perfusion in pulmonary vein stenosis after radiofrequency ablation: assessment with dynamic magnetic resonance perfusion imaging. Chest (2004) 1.13
Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation (2003) 1.12
Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry). Am J Cardiol (2005) 1.11
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy. Int J Cardiol (2013) 1.11
Pulmonary vein diameter reduction after radiofrequency catheter ablation for paroxysmal atrial fibrillation evaluated by contrast-enhanced three-dimensional magnetic resonance imaging. Circulation (2003) 1.11
Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value. Herz (2006) 1.11
TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY). EuroIntervention (2014) 1.10
Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs (2005) 1.10
Outcomes of atrial fibrillation ablation in patients with metabolic syndrome. J Am Coll Cardiol (2013) 1.06
N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J Am Coll Cardiol (2008) 1.05
Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial. Am Heart J (2012) 1.05
Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial). J Cardiovasc Magn Reson (2012) 1.05
Relationship between palpography and virtual histology in patients with acute coronary syndromes. JACC Cardiovasc Imaging (2012) 1.04
Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy. Circulation (2003) 1.03
Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry. J Cardiovasc Magn Reson (2009) 1.02
Acute coronary syndrome: the risk of being female. Circulation (2004) 1.02
How to manage patients with need for antiplatelet therapy in the setting of (un-)planned surgery. Clin Res Cardiol (2008) 0.99
MEDAFI-Trial (Micro-embolization during ablation of atrial fibrillation): comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy. Europace (2010) 0.98
Cryoballoon ablation of paroxysmal atrial fibrillation: 5-year outcome after single procedure and predictors of success. Europace (2013) 0.98